Malignant pleural effusion, current and evolving approaches for its diagnosis and management
- PMID: 16893591
- DOI: 10.1016/j.lungcan.2006.04.016
Malignant pleural effusion, current and evolving approaches for its diagnosis and management
Abstract
Malignant pleural effusion is a common and debilitating complication of advanced malignant diseases. This problem seems to affect particularly those with lung and breast cancer, contributing to the poor quality of life. Approximately half of all patients with metastatic cancer develop a malignant pleural effusion at some point, which is likely to cause significant symptoms such as dyspnea and cough. Evacuation of the pleural fluid and prevention of its re-accumulation are the main goals of management. Optimal treatment is controversial and there is no universally standard approach. Intervention options range from observation in the case of asymptomatic effusions through simple thoracentesis to more invasive methods such as chemical and mechanical pleurodesis, pleur-X catheter drainage, pleuroperitoneal shunting, and pleurectomy. The best results are reported with thoracoscopy and talc insufflation, with an acceptable morbidity. Development of novel methods to control malignant pleural effusion should be a high priority in palliative care of cancer patients. This article reviews the current, as well as, novel approaches that show some promise for the future. The aim is to identify the proper approach for each individual patient.
Comment in
-
Iodopovidone: an inexpensive and effective agent for chemical pleurodesis.Lung Cancer. 2007 Feb;55(2):253-4. doi: 10.1016/j.lungcan.2006.10.011. Epub 2006 Nov 21. Lung Cancer. 2007. PMID: 17118489 No abstract available.
Similar articles
-
[Value of thoracoscopy and talc pleurodesis in diagnosis and palliative treatment of malignant pleural mesothelioma].Praxis (Bern 1994). 1998 Mar 4;87(10):336-40. Praxis (Bern 1994). 1998. PMID: 9545840 Review. German.
-
Management of malignant pleural effusions.Respirology. 2004 Jun;9(2):148-56. doi: 10.1111/j.1440-1843.2004.00566.x. Respirology. 2004. PMID: 15182263 Review.
-
Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.Eur J Cardiothorac Surg. 2006 Dec;30(6):827-32. doi: 10.1016/j.ejcts.2006.10.002. Eur J Cardiothorac Surg. 2006. PMID: 17113008 Clinical Trial.
-
Management of malignant pleural effusions.Adv Ther. 2010 Jun;27(6):334-47. doi: 10.1007/S12325-010-0031-8. Epub 2010 Jun 10. Adv Ther. 2010. PMID: 20544327 Review.
-
Management of malignant pleural effusion.Nurs Clin North Am. 2001 Dec;36(4):665-83, vi. Nurs Clin North Am. 2001. PMID: 11726346 Review.
Cited by
-
Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.Oncotarget. 2017 Sep 15;8(47):82885-82896. doi: 10.18632/oncotarget.20889. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137310 Free PMC article.
-
The treatment of pleural carcinosis with malignant pleural effusion.Dtsch Arztebl Int. 2013 May;110(18):313-8. doi: 10.3238/arztebl.2013.0313. Dtsch Arztebl Int. 2013. PMID: 23720697 Free PMC article. Review.
-
Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.Mol Ther. 2012 Jun;20(6):1139-47. doi: 10.1038/mt.2012.4. Epub 2012 Feb 14. Mol Ther. 2012. PMID: 22334023 Free PMC article.
-
Validating LENT score in malignant pleural effusion.Future Sci OA. 2024 May 20;10(1):FSO958. doi: 10.2144/fsoa-2023-0168. eCollection 2024. Future Sci OA. 2024. PMID: 38817378 Free PMC article.
-
A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells.J Transl Med. 2015 Sep 15;13:302. doi: 10.1186/s12967-015-0662-2. J Transl Med. 2015. PMID: 26373420 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
